Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Internal Medicine
Authors: Stephanos J. Hadziyannis, Hoel Sette, Timothy R. Morgan, Vijayan Balan, Moises Diago, Patrick Marcellin, Giuliano Ramadori, Henry Bodenheimer, David Bernstein, Mario Rizzetto, Stefan Zeuzem, Paul J. Pockros, Amy Lin, Andrew M. Ackrill, for the PEGASYS International Study Group*
Institutions: Hôpital Beaujon, North Shore University Hospital, Instituto de Infectologia Emílio Ribas, Universitätsklinikum des Saarlandes, Azienda Ospedaliero Universitaria San Giovanni Battista, Mayo Clinic in Arizona, Hospital General Universitario De Valencia, Scripps Clinic, Henry Dunant Hospital, University of Turin, University of Göttingen, Icahn School of Medicine at Mount Sinai
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2112876622
